Jean-Marc P.
- Country
- France
- Department
- Hepato-gastroenterology
Research Overview
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Phase 1/2 Study of Pumitamig Monotherapy or in Combination with Ipilimumab for First-Line Advanced or Unresectable Hepatocellular Carcinoma
- Phase 3 Randomized Double-Blind Study of INCA33890 Plus First-Line Chemotherapy and Bevacizumab in Metastatic Microsatellite Stable Colorectal Cancer
Data & Insights
Has run more than one trial at 346 of 607 partner sites.
Specializations
Colorectal Cancer Research
Specializes in advancing treatment approaches for colorectal cancer, with particular focus on both early-stage and metastatic disease. Investigates innovative therapeutic strategies involving circulating tumor DNA for treatment decision-making.
- Stage II and III colon cancer management
- HER2-positive metastatic colorectal cancer
- BRAF V600E-mutated colon cancer
Explores personalized treatment approaches including neoadjuvant therapies and molecular-guided interventions.
Gastric Cancer Studies
Conducts research in gastric and gastroesophageal junction adenocarcinoma, focusing on targeted therapies and novel treatment combinations. Investigates treatments for patients with specific molecular profiles.
- HER2-positive gastric cancer
- FGFR2b overexpression in gastric cancer
- Advanced gastroesophageal treatments
Evaluates innovative therapeutic approaches for previously untreated and treatment-resistant cases.
Hepatic Oncology
Specializes in hepatocellular carcinoma treatment strategies, investigating both immunotherapy combinations and targeted approaches. Focuses on advancing first-line systemic therapies.
- Advanced liver cancer treatments
- Immunotherapy combinations
- Small bowel adenocarcinoma
Develops therapeutic strategies for unresectable and metastatic liver malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.